Respiratory-triggered three-dimensional T2-weighted MR cholangiography after injection of gadoxetate disodium: Is it still reliable?

Radiology

Volumn 255, Issue 2, 2010, Pages 451-458

  Ringe, Kristina I ^a   Gupta, Rajan T ^b   Brady, Christopher M ^b   Massey, Christopher M ^b   Hahn, Andreas ^a   Galanski, Michael ^a   Merkle, Elmar M ^b   Lotz, Joachim ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOXETIC ACID;

ADULT; AGED; ARTICLE; CHOLANGIOGRAPHY; COMMON BILE DUCT; CONTROLLED STUDY; FEMALE; HEPATIC DUCT; HEPATOBILIARY SYSTEM; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SIGNAL NOISE RATIO; THREE DIMENSIONAL IMAGING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHOLANGIOPANCREATOGRAPHY, MAGNETIC RESONANCE; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGING, THREE-DIMENSIONAL; LIVER DISEASES; MALE; MIDDLE AGED; RESPIRATORY-GATED IMAGING TECHNIQUES; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 77951448777     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.10091130     Document Type: Article

References (29)

1. Holzknecht N, Gauger J, Sackmann M, et al. Breath-hold MR cholangiography with snapshot techniques: prospective comparison with endoscopic retrograde cholangiography. Radiology 1998;206(3):657-664. (Pubitemid 28128512)
2. Hekimoglu K, Ustundag Y, Dusak A, et al. MRCP vs. ERCP in the evaluation of biliary pathologies: review of current literature. J Dig Dis 2008;9(3):162-169.
3. Krausé D, Cercueil JP, Dranssart M, Cognet F, Piard F, Hillon P. MRI for evaluating congenital bile duct abnormalities. J Comput Assist Tomogr 2002;26(4):541-552.
4. Reinhold C, Taourel P, Bret PM, et al. Choledocholithiasis: evaluation of MR cholangiography for diagnosis. Radiology 1998; 209(2):435-442.
5. Pavone P, Laghi A, Catalano C, et al. MR cholangiography in the examination of patients with biliary-enteric anastomoses. AJR Am J Roentgenol 1997;169(3):807-811.
6. Saito K, Kotake F, Ito N, et al. Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase. Magn Reson Med Sci 2005;4(1):1-9.
7. Holzapfel K, Breitwieser C, Prinz C, Rummeny EJ, Gaa J. Contrast-enhanced magnetic resonance cholangiography using gadolinium- EOB-DTPA: preliminary experience and clinical applications [in German]. Radiologe 2007;47(6):536-544.
8. Zizka J, Klzo L, Ferda J, Mrklovský M, Bukac J. Dynamic and delayed contrast enhancement in upper abdominal MRI studies: comparison of gadoxetic acid and gadobutrol. Eur J Radiol 2007;62(2):186-191. (Pubitemid 46560352)
9. Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, Speck U. Preclinical evaluation of Gd-EOBDTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 1992;183(1):59-64.
10. Kirchin MA, Pirovano GP, Spinazzi A. Gadobenate dimeglumine (Gd-BOPTA): an overview. Invest Radiol 1998;33(11):798-809.
11. Primovist [package insert]. Berlin, Germany: Schering, 2004.
12. Nikolaou K, Schoenberg SO, Brix G, et al. Quantification of pulmonary blood flow and volume in healthy volunteers by dynamic contrast-enhanced magnetic resonance imaging using a parallel imaging technique. Invest Radiol 2004;39(9):537-545. (Pubitemid 39096771)
13. Papanikolaou N, Karantanas AH, Heracleous E, Costa JC, Gourtsoyiannis N. Magnetic resonance cholangiopancreatography: comparison between respiratory-triggered turbo spin echo and breath hold single-shot turbo spin echo sequences. Magn Reson Imaging 1999;17(9):1255-1260. (Pubitemid 29534412)
14. Lim JS, Kim MJ, Myoung S, et al. MR cholangiography for evaluation of hilar branching anatomy in transplantation of the right hepatic lobe from a living donor. AJR Am J Roentgenol 2008;191(2):537-545.
15. Malone D, Zech CJ, Ayuso C, et al. Magnetic resonance imaging of the liver: consensus statement from the 1st International Primovist User Meeting. Eur Radiol Suppl 2008;18(suppl 4):849-864.
16. Stroszczynski C, Gaffke G, Gnauck M, Streitparth F, Wieners G, Lopez-Häninnen E. Current status of MRI diagnostics with liver-specific contrast agents: Gd-EOB-DTPA and Gd-BOPTA [in German]. Radiologe 2004;44(12):1185-1191. (Pubitemid 40125649)
17. Reimer P, Rummeny EJ, Shamsi K, et al. Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 1996;199(1):177-183. (Pubitemid 26098637)
18. Reimer P, Tombach B, Daldrup H, et al. New MR contrast media in liver diagnosis: initial clinical results with hepatobiliary Eovist (gadolinium-EOB-DTPA) and RESspecifi c Resovist (SH U 555 A) [in German]. Radiologe 1996;36(2):124-133.
19. Tanimoto A, Satoh Y, Yuasa Y, Jinzaki M, Hiramatsu K. Performance of Gd-EOB-DTPA and superparamagnetic iron oxide particles in the detection of primary liver cancer: a comparative study by alternative free-response receiver operating characteristic analysis. J Magn Reson Imaging 1997;7(1):120-124. (Pubitemid 28365646)
20. Carlos RC, Branam JD, Dong Q, Hussain HK, Francis IR. Biliary imaging with Gd-EOB-DTPA: is a 20-minute delay sufficient? Acad Radiol 2002;9(11):1322-1325.
21. Rodriguez M, Gnesan K, Sirlin C. Effects of extracellular hepatobiliary gadolinium based contrast agents on apparent diffusion coefficient [abstr]. In: Proceedings of the Seventeenth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2009;2068.
22. Bollow M, Taupitz M, Hamm B, Staks T, Wolf KJ, Weinmann HJ. Gadoliniumethoxybenzyl-DTPA as a hepatobiliary contrast agent for use in MR cholangiography: results of an in vivo phase-I clinical evaluation. Eur Radiol 1997;7(1):126-132. (Pubitemid 127538537)
23. Paré P, Shaffer EA, Rosenthall L. Nonvisualization of the gallbladder by 99mTc-HIDA cholescintigraphy as evidence of cholecystitis. Can Med Assoc J 1978;118(4):384-386. (Pubitemid 8312497)
24. Boraschi P, Donati F, Gigoni R, et al. Ischemictype biliary lesions in liver transplant recipients: evaluation with magnetic resonance cholangiography. Transplant Proc 2004; 36(9):2744-2747. (Pubitemid 40036826)
25. Carlos RC, Hussain HK, Song JH, Francis IR. Gadolinium-ethoxybenzyl- diethylenetriamine pentaacetic acid as an intrabiliary contrast agent: preliminary assessment. AJR Am J Roentgenol 2002;179(1):87-92.
26. Zech CJ, Herrmann KA, Reiser MF, Schoenberg SO. MR imaging in patients with suspected liver metastases: value of liverspecifi c contrast agent Gd-EOB-DTPA. Magn Reson Med Sci 2007;6(1):43-52.
27. Bader TR, Beavers KL, Semelka RC. MR imaging features of primary sclerosing cholangitis: patterns of cirrhosis in relationship to clinical severity of disease. Radiology 2003;226(3):675-685.
28. Vitellas KM, Keogan MT, Freed KS, et al. Radiologic manifestations of scleros ing cholangitis with emphasis on MR cholangiopancreatography. RadioGraphics 2000;20(4):959-975.
29. Ruemmele P, Hofstaedter F, Gelbmann CM; Medscape. Secondary sclerosing cholangitis. Nat Rev Gastroenterol Hepatol 2009;6(5):287-295.